Cargando…
Correction to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237785/ https://www.ncbi.nlm.nih.gov/pubmed/35785046 http://dx.doi.org/10.1093/immadv/ltac013 |
Ejemplares similares
-
100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes
por: Pearson, James A, et al.
Publicado: (2021) -
Correction: Immunotherapy for sarcomas: new frontiers and unveiled opportunities
Publicado: (2022) -
Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
por: Rohatgi, Anjali, et al.
Publicado: (2021) -
A Look Into the Next Century After 100 Years of Insulin
por: Gupta, Sonal, et al.
Publicado: (2022) -
Author Correction: Traps and transport resistance are the next frontiers for stable non-fullerene acceptor solar cells
por: Wöpke, Christopher, et al.
Publicado: (2022)